BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Habib S. Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping. World J Gastrointest Pathophysiol 2024; 15(2): 92791 [PMID: 38845820 DOI: 10.4291/wjgp.v15.i2.92791]
URL: https://www.wjgnet.com/1007-9327/full/v15/i2/92791.htm
Number Citing Articles
1
Shahid Habib, Andrew Johnson. An overview of pathogenesis of metabolic dysfunction-associated steatotic liver diseaseExploration of Digestive Diseases 2024; : 459 doi: 10.37349/edd.2024.00061
2
Shahid Habib. Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapyWorld Journal of Gastrointestinal Pathophysiology 2024; 15(4): 93606 doi: 10.4291/wjgp.v15.i4.93606
3
Ramasamy Selvarani, HoangVan Michelle Nguyen, Natesan Pazhanivel, Muthusamy Raman, Sunho Lee, Roman F. Wolf, Sathyaseelan S. Deepa, Arlan Richardson. The role of inflammation induced by necroptosis in the development of fibrosis and liver cancer in novel knockin mouse models fed a western dietGeroScience 2024;  doi: 10.1007/s11357-024-01418-3
4
Camilo Julio Llamoza-Torres, María Fuentes-Pardo, Bruno Ramos-Molina. Metabolic dysfunction-associated steatotic liver disease: a key factor in hepatocellular carcinoma therapy responseMetabolism and Target Organ Damage 2024; 4(4) doi: 10.20517/mtod.2024.64